Yuyu Pharma Inc (000225) — Cash Flow Reinvestment Rate
Yuyu Pharma Inc (000225) has a Cash Flow Reinvestment Rate of 1.24x as of March 2026, reinvesting ₩3.66 Billion (capex ₩3.19 Billion plus investments ₩-468.91 Million) from operating cash flow of ₩2.95 Billion. Check 000225 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yuyu Pharma Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Yuyu Pharma Inc across 9 annual periods. Explore Yuyu Pharma Inc (000225) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Yuyu Pharma Inc (2014–2025)
Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. For live market cap and broader valuation context, see 000225 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | ₩13.38 Billion | ₩15.88 Billion | ₩8.45 Billion | ▲ +126.2% |
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | — |